Recent Patents on Anti-Infective Drug Discovery
Title:Opinion Paper: Pharmacogenomics Testing for Type B Adverse Drug Reactions to Anti- Infective Drugs: The Example of Hypersensitivity to Abacavir
Volume: 9 Issue: 2
Author(s): José A.G. Agúndez, Gara Esguevillas, Gemma Amo and Elena García-Martín
Affiliation:
Export Options
About this article
Cite this article as:
A.G. Agúndez José, Esguevillas Gara, Amo Gemma and García-Martín Elena, Opinion Paper: Pharmacogenomics Testing for Type B Adverse Drug Reactions to Anti- Infective Drugs: The Example of Hypersensitivity to Abacavir, Recent Patents on Anti-Infective Drug Discovery 2014; 9 (2) . https://dx.doi.org/10.2174/1574891X10666150416130637
DOI https://dx.doi.org/10.2174/1574891X10666150416130637 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Gels and Jellies as a Dosage Form for Dysphagia Patients: A Review
Current Drug Therapy Targeted Enzyme Prodrug Therapies
Mini-Reviews in Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Infective Drug Discovery The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets Systemic Lupus Erythematosus-Related Interstitial Lung Disease
Current Rheumatology Reviews Artificial RNA Editing with ADAR for Gene Therapy
Current Gene Therapy Antiangiogenic Therapy in Acute Myelogenous Leukemia: Targeting of Vascular Endothelial Growth Factor and Interleukin 8 as Possible Antileukemic Strategies
Current Cancer Drug Targets Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab
Current Drug Targets Ovarian Stimulation: Today and Tomorrow
Current Pharmaceutical Biotechnology Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment
Current Medicinal Chemistry HDL Apolipoprotein-Related Peptides in the Treatment of Atherosclerosis and other Inflammatory Disorders
Current Pharmaceutical Design Xanthohumol, a Prenylated Chalcone Derived from Hops, Suppresses Cancer Cell Invasion through Inhibiting the Expression of CXCR4 Chemokine Receptor
Current Molecular Medicine Mitochondrial Toxicity in HAART: An Overview of In Vitro Evidence
Current Pharmaceutical Design Advancement in Shampoo (A Dermal Care Product): Preparation Methods, Patents and Commercial Utility
Recent Patents on Inflammation & Allergy Drug Discovery Lanthionine Synthetase Component C-Like Protein 2: A New Drug Target for Inflammatory Diseases and Diabetes
Current Drug Targets TRICOM Vector Based Cancer Vaccines
Current Pharmaceutical Design Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology Probiotics: An Emerging Therapy
Current Pharmaceutical Design GABAergic Agonists Modulate the Glutamate Release from Frontal Cortex Synaptosomes of Rats with Experimental Autoimmune Encephalomyelitis
Inflammation & Allergy - Drug Targets (Discontinued) Metabolic Syndrome as a Modifier of Atherosclerosis in Murine Models
Current Drug Targets